Cargando…

Inhibition of KIF20A by transcription factor IRF6 affects the progression of renal clear cell carcinoma

BACKGROUND: Renal clear cell carcinoma (ccRCC) is one of the most common malignant tumors, whose incidence is increasing year by year. IRF6 plays an important role in the occurrence of tumors, although there is yet no report on its expression in ccRCC. METHODS: The expression of IRF6 and KIF20A in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xinwei, Wang, Xiaoqi, Dong, Qian, Pang, Hongquan, Xu, Jianming, Shen, Junkang, Zhu, Jianbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091794/ https://www.ncbi.nlm.nih.gov/pubmed/33941190 http://dx.doi.org/10.1186/s12935-021-01879-y

Ejemplares similares

KIF15 is involved in development and progression of Burkitt lymphoma
por: Wang, Zhao, et al.
Publicado: (2021)

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
por: Yu, Hongbo, et al.
Publicado: (2020)

RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
por: Wang, Lei, et al.
Publicado: (2021)

MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene
por: Pu, Youguang, et al.
Publicado: (2016)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
por: Ren, Li-Xin, et al.
Publicado: (2021)

Identification of KIF20A as a tumor biomarker and forwarder of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
por: Nakken, Sigrid, et al.
Publicado: (2021)

Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma
por: Wang, Liang, et al.
Publicado: (2020)

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population
por: Zhao, Qiang, et al.
Publicado: (2020)

Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma
por: Wu, Zonglong, et al.
Publicado: (2022)

Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination
por: Jiang, Cheng-Fei, et al.
Publicado: (2021)

miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway
por: Li, Hua, et al.
Publicado: (2019)

Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p
por: Wu, Huijuan, et al.
Publicado: (2020)

KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis
por: Ding, Lixian, et al.
Publicado: (2020)

Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome
por: Ren, Xiaohan, et al.
Publicado: (2020)

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021)

IRF4 overexpression promotes the transdifferentiation of tregs into macrophage‐like cells to inhibit the development of colon cancer
por: Wang, Jiwei, et al.
Publicado: (2021)

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
por: Chen, Lujun, et al.
Publicado: (2019)

SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma
por: Shang, Xiaoling, et al.
Publicado: (2021)

IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2017)

Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
por: Jou, Yeong-Chin, et al.
Publicado: (2021)

Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients
por: Tan, Xiaojie, et al.
Publicado: (2013)

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019)

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
por: Meng, Fei, et al.
Publicado: (2021)

Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining
por: Liang, Taotao, et al.
Publicado: (2020)

miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1
por: Xie, Yongpeng, et al.
Publicado: (2020)

Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
por: Chen, Jing, et al.
Publicado: (2020)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gat5vfpn1mtli3ucv2dvecg5fo